Our cost, their price, our margin
The whole business in one table: what each prescription product costs us through the 503A network, what a named competitor charges for it, and the gross margin we keep selling at that market price. Verified June 2026.
How to read this: Our cost = our wholesale 503A cost per fill. Market price = a real published cash price from the named competitor. Margin and profitare what we capture if we simply match that market price — we don't have to undercut to win. The smaller named prices under each product are additional competitor comps; where a competitor's vial is a different dose, a per-mg equivalent is noted. Each product also carries a regulatory-footing badge: green = not restricted, amber = interim status / under FDA review, red = expected-restricted / not compoundable.
Prescribable now (503A)
FDA-approved or routinely compounded items we can prescribe and ship through the 503A network today. The anchor is a conservative named competitor price; additional named comps are listed under each.
| Product | Our cost | Market price | Competitor | Profit | Gross margin |
|---|---|---|---|---|---|
| Semaglutide (compounded)Not restrictedAnchor to ongoing price; intro floor ~$99–129. (Hims exited compounded sema after the Apr 2026 Novo settlement)Ro $149–199Eden $209–229 (no membership)AgelessRx $139 (Maximus $299) | $44 | $199 | Ro | +$155 | 78% |
| Tirzepatide (compounded)Not restrictedConservative — anchor sits at the low end of the $299–449 band (Henry Meds is the $449 top)AgelessRx $299 (ongoing)Eden $329 (ongoing)Maximus / Henry m2m $449 | $57 | $299 | AgelessRx | +$242 | 81% |
| Enclomiphene (men's T support)Not restrictedRe-anchored down — competitors charge $67–100, not $149 (~30 tabs/mo)Maximus $99.99Invigor $75 (consult + supplies incl)Hone ~$67 ($42 med + $25 membership) | $53 | $99 | Maximus | +$46 | 46% |
| SermorelinNot restrictedPer-mg: Eden ~$12.60–19.60/mg; Feel $32.80/mgStrut $119 inj / $99 oralEden $176–196 (ongoing)Feel Peptides $328 (10mg vial) | $35 | $159 | Eden / IVY RX | +$124 | 78% |
| PT-141 (bremelanotide)Not restrictedDose-matched: RWA $199 for a 20mg vial = our fill. Branded Vyleesi $800–1,000/4 doses (ceiling)iThriveMD $199/mo (20mg, LegitScript — exact match)HydraMed $299 (20mg (ceiling))Hone ~$130 (20mg + membership (floor)) | $39 | $199 | RWA Center | +$160 | 80% |
| NAD+ 1000mgNot restrictedDose-matched 1000mg telehealth runs $150–299/moIVY RX $279 (1000mg vial)HydraMed $299/moStrut Health $150+ (consult incl) | $49 | $199 | Peptide telehealth | +$150 | 75% |
| Glutathione 2000mgNot restrictedTake-home telehealth vial. AgelessRx $99 is the floor; Modern Endocrine ~$200 is in-clinic IV (different channel)IVY RX $179 (page dose-conflicted (1000 vs 2000mg))Regenics $249 (clean 2000mg take-home vial)AgelessRx $99 (floor) | $51 | $179 | IVY RX | +$128 | 72% |
| Tesamorelin 30mgNot restrictedConservative — band $150–500/mo. Verify supplier ships real tesamorelin (relabel scam common)TRT Nation $233/mo (3-mo min)Perfect B $445/cycleFeel Peptides $497 (20mg ≈ $745/30mg-eq) | $88 | $233 | TRT Nation | +$145 | 62% |
Peptide line · provider-prescribed (regulatory status unresolved)
Peptides our provider network prescribes and the 503A network fulfills today. The 2026 peptide-'reclassification' headlines overstate the law: FDA's April 2026 503A action (FR 2026-07361) removed 12 of these from Category 2 because nominations were withdrawn — not because they were cleared. A PCAC advisory review of BPC-157, TB-500, MOTS-C, KPV, Semax, Epitalon and DSIP is set for July 23–24, 2026, with notice-and-comment rulemaking still required after. CJC-1295, ipamorelin, AOD-9604 and Thymosin α-1 were already voted down by PCAC in 2024. Status unresolved — not 'legal again'; eligibility confirmed per launch.
| Product | Our cost | Market price | Competitor | Profit | Gross margin |
|---|---|---|---|---|---|
| BPC-157 20mgUnder PCAC review · Jul '26Marek 15mg $350 ≈ $467/20mg-eq — anchor is cheap per-mg vs premium clinicsPeRx $175–299/moDefy $160 (5mg vial)Marek $350 (15mg vial) | $39 | $199 | BeyondMD | +$160 | 80% |
| MOTS-C 25mgUnder PCAC review · Jul '26Feel 50mg $540 ≈ $270/25mg-eq; single-peptide floor ~$96–200/moTrimRX $50–200 (per vial)Perfect B $445/cycleFeel Peptides $540 (50mg vial) | $29 | $165 | Sky Health | +$136 | 82% |
| TB-500 10mgUnder PCAC review · Jul '26Conservative — Feel $277 for the same 10mg sits above the anchorFeel Peptides $277 (10mg — exact dose match)Marek bundle tiers (not cleanly public) | $44 | $199 | Peptide clinics | +$155 | 78% |
| GLOW (BPC / TB-500 / GHK)Under PCAC review · Jul '26Category estimate — no like-for-like blend sold publiclyFeel (à la carte) TB-500 $277 + GHK $273 (components far exceed $199)Perfect B $445/cycle | $58 | $199 | Recovery-blend programs | +$141 | 71% |
| CJC-1295 / IpamorelinInterim Cat-1 · rejected '24Interim Cat-1 since Apr 2026 (compoundable under 503A discretion), but PCAC voted against permanent listing in 2024 — longest-term risk of the peptide line. Concierge MD is the $399/mo ceiling; Perfect B ~$148/mo cycleConcierge MD $399/mo (concierge ceiling)Cryohealthcare $320 (5/5mg, 6wk all-in)Perfect B ~$148/mo ($445/cycle + $150 consult) | $49 | $320 | Cryohealthcare | +$271 | 85% |
| RetatrutideNot legally compoundable⚠ NOT legally compoundable — no approved product, not on the 503A/503B bulks list. FDA issued warning letters (Sep 9 2025) calling compounded retatrutide unapproved/misbranded drugs; named sellers are active enforcement targets. Recommend removing from the catalogCompounded telehealth $200–650/moSeekPeptides survey $450–700/moResearch vials $120–370 (10–30mg) | $135 | $349 | Not legally compoundable | +$214 | 61% |
The takeaway
We don't compete on price. We compete on cost.
Every competitor in the right-hand column is buying the same molecules we are. Because our cost basis is the 503A wholesale price, we can match the exact rate Hims, Henry Meds, or any peptide clinic charges and still keep 72% of the order. The pending Category-2 reclassification only widens the menu — at the same margins.
See the full 147-item price listOur cost = current 503A wholesale per fill. Market prices are published competitor cash rates (June 2026); see the competitors page for sources. Doses titrate, so per-fill cost varies; figures are representative and confirmed per launch. Category estimates are labeled where no direct competitor price is published.
average gross margin at market price
We match what the market already charges and keep the spread — across three brands on one shared backend.